226917-15-3 Usage
General Description
2-(Dimethylamino)-6-methyl-4-pyridinecarboxylic acid, also known as DMAP, is a chemical compound commonly used as a catalyst in organic synthesis. It is a strong nucleophilic base that is particularly effective in promoting esterification and acylation reactions. DMAP is a white crystalline solid with a characteristic amine odor, and it is soluble in organic solvents such as dichloromethane and dimethylformamide. It is commonly used in the pharmaceutical and fine chemical industries for the synthesis of various compounds, including pharmaceutical intermediates and natural products. DMAP is also used in the production of polymers and dyes, and it has applications in the development of new materials and chemical processes. Overall, DMAP is a versatile and important chemical that plays a crucial role in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 226917-15-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,6,9,1 and 7 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 226917-15:
(8*2)+(7*2)+(6*6)+(5*9)+(4*1)+(3*7)+(2*1)+(1*5)=143
143 % 10 = 3
So 226917-15-3 is a valid CAS Registry Number.
InChI:InChI=1/C9H12N2O2/c1-6-4-7(9(12)13)5-8(10-6)11(2)3/h4-5H,1-3H3,(H,12,13)
226917-15-3Relevant articles and documents
NOVEL PYRIMIDINE-PYRIDINE DERIVATIVES
-
, (2011/04/14)
The invention relates to novel pyrimidine-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
AMINO-PYRIDINE DERIVATIVES AS S1P1 /EDG1 RECEPTOR AGONISTS
-
Page/Page column 12, (2010/04/30)
The invention relates to novel amino-pyridine derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents.
PYRIDINE DERIVATIVES AS S1P1/EDG1 RECEPTOR MODULATORS
-
Page/Page column 50-51, (2009/04/25)
The invention relates to novel pyridine derivatives of formula (D, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunomodulating agents. Formula (I) wherein A represents and the other substituants are as defined in the claims.
